Subscribe To
eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen
TOKYO , Nov. 20, 2022 /PRNewswire/ -- eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "...
November 20, 2022, 6:30 pm
eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen
TOKYO , Nov. 20, 2022 /PRNewswire/ -- eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "...
November 20, 2022, 6:30 pm
eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen
TOKYO , Nov. 20, 2022 /PRNewswire/ -- eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "...
November 20, 2022, 6:30 pm
eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen
TOKYO , Nov. 20, 2022 /PRNewswire/ -- eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "...
November 20, 2022, 6:30 pm
eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen
TOKYO , Nov. 20, 2022 /PRNewswire/ -- eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "...
November 20, 2022, 6:30 pm
eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen
TOKYO , Nov. 20, 2022 /PRNewswire/ -- eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "...
November 20, 2022, 6:30 pm
eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen
TOKYO , Nov. 20, 2022 /PRNewswire/ -- eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "...
November 20, 2022, 6:30 pm
eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen
TOKYO , Nov. 20, 2022 /PRNewswire/ -- eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "...
November 20, 2022, 6:30 pm
eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen
TOKYO , Nov. 20, 2022 /PRNewswire/ -- eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "...
November 20, 2022, 6:30 pm
eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen
TOKYO , Nov. 20, 2022 /PRNewswire/ -- eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "...
November 20, 2022, 6:30 pm
Budweiser shrugs off qatar stadium beer ban, tweets new world cup campaign
World Cup beer sponsor Budweiser, which appeared to be caught unawares by Qatar's abrupt ban on stadium...
November 19, 2022, 2:02 pm
As qatar bans beer in stadiums, world cup sponsor budweiser touts promotional efforts in other countries
The shock decision by Qatar and FIFA to ban beer sales in stadiums appeared to catch World Cup sponsor Budweis...
November 19, 2022, 11:55 am
What is bud zero, the only beer budweiser can sell at the world cup?
In a surprise reversal, Qatar announced a ban of alcoholic beer at the eight stadiums hosting the World Cup. That leaves fans with just one "beer" cho...
November 19, 2022, 11:09 am
Gamestop leads spdr s&p retail etf higher
CNBC's Sara eisen reports on the ETF spotlight....
November 19, 2022, 8:51 am
Coty ceo: kylie beauty is an invaluable asset
Coty CEO Sue Nabi spoke with CNBC's Sara eisen on the company's outlook after weak sales and how busine...
November 19, 2022, 8:34 am
Gaming and leisure properties: a good bet for income and growth
Gaming and Leisure Properties' triple-net lease business model helps to shield it from near-term econom...
November 19, 2022, 8:05 am
Stocks to watch: oracle and adobe, which report next week
A look at Oracle, Adobe, which are set to report earnings next week, and General Motors, with CNBC's Scott Wapner and the 'Halftime Report' traders, S...
November 19, 2022, 7:28 am
Going viral: qatar's beer ban
Caroline Hyde and Ed Ludlow discuss why Qatari officials are set to ban the sale of alcohol within its World Cup stadiums, in a dramatic reversal of a...
November 18, 2022, 8:10 pm
As qatar bans beer in stadiums, world cup sponsor budweiser touts promotional efforts in other countries
The shock decision by Qatar to ban beer sales in stadiums appeared to leave World Cup sponsor Budweiser...
November 18, 2022, 7:02 pm
Itafos announces final environmental impact statement for conda mine life extension
HOUSTON, Nov. 18, 2022 (GLOBE NEWSWIRE) — Itafos Inc. (TSX-V: IFOS) (“Itafos” or the “Company”) announced today the publication of the Final...
November 18, 2022, 3:55 pm